Evidence map›Paper›PMID 34166850›Full record

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2021

New Pulmonary Infiltrates Observed on Computed Tomography-Based Image Guidance for Radiotherapy Warrant Diagnostic Workup for Coronavirus Disease 2019.

Graham W Warren, Vun-Sin Lim, Mudit Chowdhary, Gaurav Marwaha, Osama Mostafa Abd Elbadee, Esra Korkmaz Kirakli, Charlotte Billiet, Alexandra Giraldo Marin, Monica Ramos, Morten Hiul Suppli and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 9 institutions in 5 countries.

Graham W WarrenDepartment of Radiation Oncology, Medical University of South Carolina, Charleston, South Carolina. Electronic address: warrengw@musc.edu.
Vun-Sin LimInternational Association for the Study of Lung Cancer, Denver, Colorado.
Mudit ChowdharyDepartment of Radiation Oncology, Rush University Medical Center, Chicago, Illinois.
Gaurav MarwahaDepartment of Radiation Oncology, Rush University Medical Center, Chicago, Illinois.
Osama Mostafa Abd ElbadeeRadiotherapy Department, South Egypt Cancer Institute, Assuit, Egypt.
Esra Korkmaz KirakliDepartment of Radiation Oncology, Dr. Suat Seren Chest Diseases and Surgery Research and Training Hospital, Ismir, Turkey.
Charlotte BillietDepartment of Radiation Oncology, Iridium Netwerk, Antwerp, Belgium; Center for Oncological Research (CORE), Integrated Personalized and Precision Oncology Network (IPPON), University of Antwerp, Antwerp, Belgium.
Alexandra Giraldo MarinDepartment of Radiation Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
Monica RamosDepartment of Radiation Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
Morten Hiul SuppliDepartment of Oncology, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Gwendolyn J McGinnisDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.
Alex A AdjeiDepartment of Oncology and Pharmacology, Mayo Clinic, Rochester, Minnesota.
Rush University Medical Center · USVall d'Hebron Hospital Universitari · ESChildren Cancer Hospital · EGCopenhagen University Hospital · DKInternational Association for the Study of Lung Cancer · USMayo Clinic · USMedical University of South Carolina · USThe University of Texas MD Anderson Cancer Center · USUniversity of Antwerp · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionScreening for coronavirus disease 2019 (COVID-19) exposure, coupled with engaged decision making to prioritize cancer treatment in parallel with reducing risk of exposure and infection, is crucial in the management of COVID-19 during cancer treatment. After two reported case studies of imaging findings during daily computed tomography (CT)-based image-guided radiotherapy (RT) scans, a call for submission of anonymized case reports was published with the objective of rapidly determining if there was a correlation between the onset of new pulmonary infiltrates found during RT and COVID-19. We hereby report the results of the aggregate analysis.

methodsData of deidentified case reports for patients who developed biochemically confirmed COVID-19 during RT were submitted through an online portal. Information requested included a patient's sex, age, cancer diagnosis and treatment, and COVID-19 diagnosis and outcome. Coplanar CT-based imaging was requested to reveal the presence or absence of ground-glass opacities or infiltrates.

resultsA total of seven reports were submitted from Turkey, Spain, Belgium, Egypt, and the United States. Results and imaging from the patients reported by Suppli et al. and McGinnis et al. were included for a total of nine patients for analysis. All patients were confirmed COVID-19 positive using polymerase chain reaction-based methods or nasopharyngeal swabs. Of the nine patients analyzed, abnormalities consistent with ground-glass opacities or infiltrates were observed in eight patients.

conclusionsThis is the largest case series revealing the potential use of CT-based image guidance during RT as a tool for identifying patients who need further workup for COVID-19. Considerations for reviewing image guidance for new pulmonary infiltrates and immediate COVID-19 testing in patients who develop new infiltrates even without COVID-19 symptoms are strongly encouraged.

Indexed as

COVID-19Lung NeoplasmsCOVID-19 TestingHumansLungSARS-CoV-2Tomography, X-Ray ComputedComputed tomographyCOVID-19Ground-glass opacitiesRadiotherapy

Identifiers

PMID34166850
PMCPMC8216849
OpenAlexW3176122924

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.